Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases

Pola Olczak, Richard B.S. Roden

Open source

DOI
10.3390/vaccines8040568
Published
2020-10-01
Container
Vaccines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines8040568,
  title = {Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases},
  author = {Pola Olczak and Richard B.S. Roden},
  year = {2020},
  journal = {Vaccines},
  doi = {10.3390/vaccines8040568},
  url = {https://doi.org/10.3390/vaccines8040568}
}

RIS

TY  - JOUR
TI  - Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases
AU  - Pola Olczak
AU  - Richard B.S. Roden
PY  - 2020
JO  - Vaccines
DO  - 10.3390/vaccines8040568
UR  - https://doi.org/10.3390/vaccines8040568
ER  - 

APA

Olczak, P., & Roden, R. B. (2020). Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases. Vaccines. https://doi.org/10.3390/vaccines8040568

Source records